Ranbaxy Wins DGCI Approval To Export ‘Quetiapine Hemifumarate’ To UK

RanbaxyNew Delhi: Drugs Controller General of India (DGCI) has given authorization to Ranbaxy Laboratories to export 10.2 lakh tabs in different quantities of anti-psychotic drug quetiapine hemifumarate to the United Kingdom.

The DGCI allotted no objection certificate to the company last month to export six different drug quantities.

In its sanction letter to the Ranbaxy, DGCI permitted the company to export 1.8 lakh pills of quetiapine 50 mg, 3.6 lakh tabs of quetiapine 25 mg and 1.2 lakh tablets each of quetiapine 100 mg, 150 mg, 200 mg and 300 mg.